SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-333983
Filing Date
2021-11-18
Accepted
2021-11-18 17:18:02
Documents
16
Period of Report
2021-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d166338d8k.htm   iXBRL 8-K 26123
2 EX-1.1 d166338dex11.htm EX-1.1 191629
3 EX-4.1 d166338dex41.htm EX-4.1 63569
4 EX-5.1 d166338dex51.htm EX-5.1 13634
8 GRAPHIC g166338g1118160337171.jpg GRAPHIC 2408
  Complete submission text file 0001193125-21-333983.txt   499726

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20211117.xsd EX-101.SCH 2890
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20211117_lab.xml EX-101.LAB 18140
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20211117_pre.xml EX-101.PRE 11407
9 EXTRACTED XBRL INSTANCE DOCUMENT d166338d8k_htm.xml XML 3359
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 211425383
SIC: 2834 Pharmaceutical Preparations